Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies
US-10525129-B2 · Jan 7, 2020 · US
This page is not indexed by search engines while we improve data quality.
Johnson Peter — Human Necessities
Johnson Peter holds 5 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Johnson Peter |
| Technology | Human Necessities |
| Patents in slice | 5 |
| Recent patents in slice | 0 |
| First year | 2016 |
| Last year | 2020 |
Representative patents
Notable publications linking Johnson Peter to Human Necessities.
Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies
US-10525129-B2 · Jan 7, 2020 · US
Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies
US-10525129-B2 · Jan 7, 2020 · US
Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies
US-10525129-B2 · Jan 7, 2020 · US
Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies
US-10525129-B2 · Jan 7, 2020 · US
Recent filings
Latest patents from Johnson Peter in Human Necessities.
Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies
US-10525129-B2 · Jan 7, 2020 · US
Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies
US-10525129-B2 · Jan 7, 2020 · US
Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies
US-10525129-B2 · Jan 7, 2020 · US
Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies
US-10525129-B2 · Jan 7, 2020 · US
Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies
US-10525129-B2 · Jan 7, 2020 · US
Related pages
Navigate to parent entity pages.